PUMA BIOTECHNOLOGY, INC.: capex
| Value | {"amount": 0, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-03-31 |
| Status | current |
| Entity | PUMA BIOTECHNOLOGY, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:37:37.097938+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/cffbd8b8-5702-4d6a-8a38-0d90d19de1b5
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001437749-25-015533Retrieved: 2026-08-19T13:37:37.097938+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001401667/capex/2024-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/cffbd8b8-5702-4d6a-8a38-0d90d19de1b5
History
- no predecessors — first report